Aravax

Aravax is developing the first safe, convenient, and disease-modifying treatment for peanut allergy with their lead product, PVX108. This solution has the potential to revolutionise the treatment of peanut allergies and have life-changing impacts for the health and wellbeing for those living with condition.

Year Established: 2014
Lead Researcher: Robyn O’Hehir
Website: aravax.com.au